<qa>  What is the treatment with rituximab or B cell-targeted- Treatment with rituximab or a B cell-targeted therapy e.g., anti-cluster of differentiation CD 20 CD20, anti CD22, or anti-B-lymphocyte stimulator BLyS within 12 months prior to randomization 